Joseph Schoepfer

4.1k total citations
43 papers, 2.0k citations indexed

About

Joseph Schoepfer is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Joseph Schoepfer has authored 43 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 12 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in Joseph Schoepfer's work include Chemical Synthesis and Analysis (10 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Heat shock proteins research (9 papers). Joseph Schoepfer is often cited by papers focused on Chemical Synthesis and Analysis (10 papers), Protein Kinase Regulation and GTPase Signaling (9 papers) and Heat shock proteins research (9 papers). Joseph Schoepfer collaborates with scholars based in Switzerland, United States and Germany. Joseph Schoepfer's co-authors include Pascal Furet, Carlos Garcı́a-Echeverrı́a, Heinz Fretz, Giorgio Caravatti, Joseph Rahuel, Patrick Chêne, Brigitte Gay, Michael Rugaard Jensen, Thomas Radimerski and Doriano Fabbro and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Joseph Schoepfer

43 papers receiving 2.0k citations

Peers

Countries citing papers authored by Joseph Schoepfer

Since Specialization

Citations

This map shows the geographic impact of Joseph Schoepfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Schoepfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Schoepfer more than expected).

Fields of papers citing papers by Joseph Schoepfer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Schoepfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Schoepfer. The network helps show where Joseph Schoepfer may publish in the future.

Co-authorship network of co-authors of Joseph Schoepfer

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Schoepfer. A scholar is included among the top collaborators of Joseph Schoepfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Schoepfer. Joseph Schoepfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A kinase inhibitor which specifically targets the ABL myristate pocket (STAMP), but unlike asciminib crosses the blood–brain barrier 2022 ·Bioorganic & Medicinal Chemistry Letters ·Paul W. Manley, Felix Huth, Saliha Moussaoui, Joseph Schoepfer	5
2	Capmatinib (INC280) Is Active Against Models of Non–Small Cell Lung Cancer and Other Cancer Types with Defined Mechanisms of MET Activation 2019 ·Clinical Cancer Research ·Sabrina Baltschukat, Barbara Schacher Engstler, Alan Huang, Huai-Xiang Hao, Angela Tam, Hui Qin Wang, Jinsheng Liang, Matthew T. DiMare, Hyo-Eun Carrie Bhang, Youzhen Wang, Pascal Furet, William R. Sellers, Francesco Hofmann, Joseph Schoepfer, Ralph Tiedt	105
3	A Drug Resistance Screen Using a Selective MET Inhibitor Reveals a Spectrum of Mutations That Partially Overlap with Activating Mutations Found in Cancer Patients 2011 ·Cancer Research ·Ralph Tiedt, (unknown), Pascal Furet, B.A. Appleton, (unknown), Joseph Schoepfer, Emily Buck, David A. Ruddy, John E. Monahan, Michael D. Jones, Jutta Blank, Dorothea Haasen, Peter Drueckes, Markus Wartmann, Clive McCarthy, William R. Sellers, Francesco Hofmann	99
4	Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800 2010 ·Molecular Cancer Therapeutics ·Andrew J. Massey, Joseph Schoepfer, Paul A. Brough, Josef Brueggen, Patrick Chêne, Martin J. Drysdale, Ulrike Pfaar, Thomas Radimerski, Stephan Ruetz, Alain Schweitzer, Mike Wood, Carlos Garcı́a-Echeverrı́a, Michael Rugaard Jensen	50
5	Abstract #5649: Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial 2009 ·Cancer Research ·Michael Rugaard Jensen, Susan Ide, Josef Brueggen, Joseph Schoepfer, Xiaofeng Wang, Cornelia Quadt, Carlos Garcı́a-Echeverrı́a	2
6	Anti‐myeloma activity of the novel 2‐aminothienopyrimidine Hsp90 inhibitor NVP‐BEP800 2009 ·British Journal of Haematology ·Thorsten Stühmer, Manik Chatterjee, (unknown), Ruth Seggewiss, Christian Langer, Sabine Müller, Joseph Schoepfer, Carlos Garcı́a-Echeverrı́a, Cornelia Quadt, Michael Rugaard Jensen, Hermann Einsele, Ralf C. Bargou	14
7	Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I 2009 ·Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Joseph Schoepfer, Thomas Radimerski, Patrick Chêne	43
8	Catalytic inhibition of topoisomerase II by a novel rationally designed ATP-competitive purine analogue 2009 ·SHILAP Revista de lepidopterología ·Patrick Chêne, (unknown), Joseph Schoepfer, Pascal Furet, Peter Meier, (unknown), (unknown), Rita Schmitz, Thomas Radimerski	71
9	Entry into a new class of protein kinase inhibitors by pseudo ring design 2008 ·Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Giorgio Caravatti, Vito Guagnano, Marc Lang, Thomas Meyer, Joseph Schoepfer	46
10	NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer models 2008 ·Breast Cancer Research ·Michael Rugaard Jensen, Joseph Schoepfer, Thomas Radimerski, Andrew J. Massey, Chantale T. Guy, Josef Brueggen, Cornelia Quadt, Alan Buckler, Robert Cozens, Martin J. Drysdale, Carlos Garcı́a-Echeverrı́a, Patrick Chêne	189
11	Convergent synthesis of potent peptide inhibitors of the Grb2-SH2 domain by palladium catalyzed coupling of a terminal alkyne 2001 ·Bioorganic & Medicinal Chemistry Letters ·Joseph Schoepfer, (unknown), Nicole End, Evelyne Muller, (unknown), Giorgio Caravatti, Pascal Furet	10
12	Novel Cdk Inhibitors Restore TGF-β Sensitivity in Cdk4 Overexpressing Epithelial Cells 2000 ·Biochemical and Biophysical Research Communications ·Rajeev Soni, Heinz Fretz, Lionel Muller, Joseph Schoepfer, Bhabatosh Chaudhuri	8
13	Inhibition of Cyclin-Dependent Kinase 4 (Cdk4) by Fascaplysin, a Marine Natural Product 2000 ·Biochemical and Biophysical Research Communications ·Rajeev Soni, Lionel Muller, Pascal Furet, Joseph Schoepfer, Christine Stephan, Sabine Zumstein-Mecker, Heinz Fretz, Bhabatosh Chaudhuri	141
14	Structure-based Design of Compounds Inhibiting Grb2-SH2 Mediated Protein-protein Interactions in Signal Transduction Pathways 2000 ·Current Pharmaceutical Design ·Heinz Fretz, Pascal Furet, Carlos Garcı́a-Echeverrı́a, Joseph Rahuel, Joseph Schoepfer	50
15	Highly potent inhibitors of the Grb2-SH2 domain 1999 ·Bioorganic & Medicinal Chemistry Letters ·Joseph Schoepfer, Heinz Fretz, Brigitte Gay, Pascal Furet, Carlos Garcı́a-Echeverrı́a, Nicole End, Giorgio Caravatti	37
16	Selective GRB2 SH2 inhibitors as anti-Ras therapy 1999 ·International Journal of Cancer ·Brigitte Gay, (unknown), Giorgio Caravatti, Pascal Furet, Thomas Meyer, Joseph Schoepfer	61
17	Effect of Potent and Selective Inhibitors of the Grb2 SH2 Domain on Cell Motility 1999 ·Journal of Biological Chemistry ·(unknown), Stéphanie Suarez, Christian Weber, Joseph Rahuel, (unknown), Pascal Furet, Giorgio Caravatti, Joseph Schoepfer	46
18	Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands 1998 ·Journal of Molecular Biology ·Joseph Rahuel, Carlos Garcı́a-Echeverrı́a, Pascal Furet, André Strauss, Giorgio Caravatti, Heinz Fretz, Joseph Schoepfer, (unknown)	49
19	Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain 1998 ·Bioorganic & Medicinal Chemistry Letters ·Joseph Schoepfer, (unknown), Giorgio Caravatti, Carlos Garcı́a-Echeverrı́a, Heinz Fretz, Joseph Rahuel, Pascal Furet	16
20	The stereochemistry of the 1,4-elimination of thiocyanic acid from hex-3-ene-2,5-diyl dithiocyanates 1993 ·Journal of the Chemical Society Chemical Communications ·Joseph Schoepfer, E. Eichenberger, Reinhard Neier	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact